Interventional radiology in the elderly

Department of Interventional Radiology, Guy's and St.Thomas' Hospital, NHS Foundation Trust, London, UK.
Clinical Interventions in Aging (Impact Factor: 2.08). 02/2009; 4:1-15.
Source: PubMed


Interventional radiological percutaneous procedures are becoming all the more important in the curative or palliative management of elderly frail patients with multiple underlying comorbidities. They may serve either as alternative primary minimally invasive therapies or adjuncts to traditional surgical treatments. The present report provides a concise review of the most important interventional radiological procedures with a special focus on the treatment of the primary debilitating pathologies of the elderly population. The authors elaborate on the scientific evidence and latest developments of thermoablation of solid organ malignancies, palliative stent placement for gastrointestinal tract cancer, airway stenting for tracheobronchial strictures, endovascular management of aortic and peripheral arterial vascular disease, and cement stabilization of osteoporotic vertebral fractures. The added benefits of high technical and clinical success coupled with lower procedural mortality and morbidity are highlighted.

Download full-text


Available from: Konstantinos Katsanos, Jul 15, 2014
  • Source
    • "Thermal ablative procedures in clinical practice comprise radiofrequency (RF) ablation, microwave ablation therapy (MWA), high-intensity focused ultrasound (HIFU), and laser-induced thermotherapy (LITT) with the use of high temperatures, as well as cryoablation with induction of low temperatures. Primarily all these techniques were applied for the palliative treatment of patients not eligible for surgical resection or frail patients with a reduced functional reserve capacity and many comorbidities [2] [3]. Local thermal ablative methods present several advantages as compared with surgery which include less damage to surrounding healthy tissue, greater patient comfort, for example, less pain and limitation in exercise due to wound healing, improved cosmetic results, and—in times of critical financial situations in the medical facilities—reduced cost and shorter periods of hospitalization [2] [4]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Over the past decades, thermoablative techniques for the therapy of localized tumors have gained importance in the treatment of patients not eligible for surgical resection. Anecdotal reports have described spontaneous distant tumor regression after thermal ablation, indicating a possible involvement of the immune system, hence an induction of antitumor immunity after thermoinduced therapy. In recent years, a growing body of evidence for modulation of both adaptive and innate immunity, as well as for the induction of danger signals through thermoablation, has emerged. Induced immune responses, however, are mostly weak and not sufficient for the complete eradication of established tumors or durable prevention of disease progression, and combination therapies with immunomodulating drugs are being evaluated with promising results. This article aims to summarize published findings on immune modulation through radiofrequency ablation, cryoablation, microwave ablation therapy, high-intensity focused ultrasound, and laser-induced thermotherapy.
    Clinical and Developmental Immunology 12/2011; 2011:160250. DOI:10.1155/2011/160250 · 2.93 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Obstructive ileocolitis, a complication of colorectal cancer, may be secondary to ischemia. We present a retrospective analysis of the long-term clinical characteristics of patients with obstructive ileocolitis caused by colorectal cancer. A retrospective review of 363 cases of patients with obstructive ileocolitis caused by colorectal cancer. Of 363 patients with obstruction, 56 patients had ischemic ileocolitis. There was a higher percentage of patients who presented with obstructive colitis with left-sided cancers (P = 0.0389). The majority of patients with colorectal cancer and obstructive ileocolitis had a tumor size <6 cm (P = 0.0524). Four patients had a perforation in the ischemic group as compared with only two patients in the non-ischemic group with a perforation (P = 0.0061). In the ischemic group, there were 50 patients (50/56; 89.3%) who underwent anastomosis without leakage. There were 13 patients with only segmental ischemia for which an anterior resection with anastomosis was performed. There was no statistical difference between the two groups with regards to overall morbidity or survival (P = 0.7915). However, there was a survival difference based on tumor morphology in the ischemic group with ulcerative and polypoid cancer 4.43 times more hazardous compared with annular cancer (95% CI: 1.16-12.15; P = 0.0038). Obstructive ileocolitis occurs mostly in left-sided obstruction and there are no survival differences between the groups with and without ischemia. In addition, patients who present with colorectal cancer-induced obstructive ileocolitis may be safely treated with satisfactory outcomes.
    Japanese Journal of Clinical Oncology 05/2010; 40(10):927-32. DOI:10.1093/jjco/hyq072 · 2.02 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Minimally invasive image-guided insertion of self-expanding metal stents in the upper gastrointestinal tract is the current treatment of choice for palliation of malignant esophageal or gastroduodenal outlet obstructions. A concise review is presented of contemporary stenting practice of the upper gastrointestinal tract, and the procedures in terms of appropriate patient evaluation, indications, and contraindications for treatment are analyzed, along with available stent designs, procedural steps, clinical outcomes, inadvertent complications, and future technology. Latest developments include biodegradable polymeric stents for benign disease and radioactive or drug-eluting stents for malignant obstructions.
    CardioVascular and Interventional Radiology 08/2010; 33(4):690-705. DOI:10.1007/s00270-010-9862-6 · 2.07 Impact Factor
Show more